Pages

Wednesday, December 7, 2011

John Lechleiter: 'The Biomedical Century' - WSJ.com

Amidst all of the doom and gloom of patent clifts, global economic crises, falling medicare reimbursement rates, and until recently, low FDA approval rates, I found this interview with the CEO of Lilly to be uplifting. Good to be reminded of the potential of biomedical research, and good to hear a positive message from an industry CEO?